Madame Bioscience Public Company Limited reported its second-quarter 2026 operating results, with net profit of 35.79 million baht, an increase of 118.40% from the same period last year. Sales revenue stood at 432.41 million baht, up 14.56%, while gross profit margin improved to 32.80% from 28.60%. The main driver was the skincare and health business under the Madame Louise brand, which generated revenue of 118.03 million baht this quarter, compared to 51.68 million baht in the same quarter last year, and achieved a gross profit margin as high as 79.66%. The company completed its capital restructuring this quarter, resulting in a return to accumulated profits of 152.54 million baht and total shareholders' equity of 849.19 million baht, an increase of 6.99% from the end of 2025. Total liabilities decreased by 47.29 million baht, or 9.04%, due to repayment of debts and trade payables, reducing financial costs to 4.13 million baht from 8.33 million baht. For the first six months of 2026, the company posted sales revenue of 810.76 million baht, up 14.96%, and net profit of 56.35 million baht. The net profit for the same period last year of 244.65 million baht included extraordinary income from fire insurance claims of approximately 384.67 million baht. Excluding that item, the first-half 2026 operating performance improved.
Madame Bioscience Public Company LimitedQ2 net profit up 118% and improved gross margin, driven by Madame Louise brand.
